semaglutide suspension 🚨REAL PATIENT FEEDBACK Semaglutide Injections | Semaglutide Delivered

Stomach pain was the main issue reported

Published 25 May 2026 Reading time 16 minutes Last reviewed 25 May 2026 TRIUMPH-1 Phase 3 n = 2,339 "The largest weight loss ever observed for a non-surgical obesity treatment" 28.3% Average body weight loss (12 mg, 80 weeks) 30.3% Average weight loss (BMI 35 extension, 104 weeks) 45.3% Of 12 mg participants past the 30% threshold 24.1 cm Average waist circumference reduction at 12 mg The 30-second version What happened: On 21 May 2026, Eli Lilly published topline TRIUMPH-1 Phase 3 results for retatrutide

If you have these symptoms, try having liquid or food containing sugar (around 15-20 grams) drinking juice, having regular soda, or eating some hard candies right away, as this will help raise your blood sugar quickly

Y., Longuet, C., et al

However, this is only after the first injection

Summary: Retatrutide is an unlicensed investigational triple agonist associated with dose-dependent increases in resting heart rate, though dedicated cardiovascular outcomes trial data are not yet available